U.S., Nov. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07923617) titled 'Lisdexamfetamine For the Treatment of Conduct Disorder in Children' on Nov. 02.
Brief Summary: About 2 in every 100 Australian children have conduct disorder, a serious mental health condition characterised by antisocial behaviours like aggression and rule breaking. This condition leads to big problems not only for the children but also for their families. Despite its major impacts, conduct disorder is not well understood, and treatments are limited. Talk therapy works best, but it's hard to access and is expensive. Current medications can help but often cause unwanted side effects. Stimulant medications (like those used for Attentio...